ANG and amyotrophic lateral sclerosis: Since our results from ALS patients indicated that higher ANG activity or stability could be deleterious post-onset, a higher 10 μg dose of ANG was administered intraperitoneally (i.p.)3 times/week to tgSOD1G93A-ALS mice following the onset of ALS symptoms.